Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NUDT1 | P36639 | 4/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.43 |
| ▸ | PNP | P00491 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | PI4KA | P42356 | 5/20 | 0.38 |
| ▸ | PI4K2B | Q8TCG2 | 5/20 | 0.38 |
| ▸ | PI4K2A | Q9BTU6 | 5/20 | 0.38 |
| ▸ | PI4KB | Q9UBF8 | 5/20 | 0.38 |
| ▸ | AKT2 | P31751 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30534246 | 0.81 | AKT2 (0.46) | NUDT1ADORA2AADORA1MAPTPI4KA | |
| SCHEMBL29400753 | 0.79 | ADORA2A (0.66) | NUDT1ADORA2AADORA1ALDH1A1PI4KA | |
| SCHEMBL42314 | 0.79 | ADORA2A (0.66) | NUDT1ADORA2AADORA1ALDH1A1PI4KA | |
| SCHEMBL6831171 | 0.76 | ADORA2A (0.52) | NUDT1ADORA2AADORA1PNPKDM4E | |
| SCHEMBL1868817 | 0.76 | ADORA2A (0.43) | NUDT1ADORA2AADORA1PNPKDM4E | |
| SCHEMBL6829681 | 0.76 | ADORA2A (0.43) | NUDT1ADORA2AADORA1PNPKDM4E | |
| SCHEMBL5667619 | 0.76 | ADORA2A (0.43) | NUDT1ADORA2AADORA1PNPKDM4E | |
| SCHEMBL6826187 | 0.76 | NUDT1 (0.44) | NUDT1ADORA2AADORA1PNPKDM4E | |
| SCHEMBL6360434 | 0.76 | NUDT1 (0.36) | NUDT1ADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL5490464 | 0.76 | KDM4E (0.44) | NUDT1ADORA2AADORA1PNPKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6620599-B1 | Inoculating plants in cultures and mixtures comprising auxins and cytokinins, then incubating, extracting in solvents and filtering to obtain flavonoids | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-09-16 | — | — | US | claimed |
| US-6365757-B1 | CULTURING TISSUES OF TAXUS WALLICHIANIA; ISOLATION BY PARTITIONING THE CULTURE PRODUCT RESIDUE, OBTAINED BY POLAR SOLVENT EXTRACTION; DESOLVENTIZING BETWEEN WATER AND CHLORINATED SOLVENTS; EVAPORATION; CHROMOTOGRAPHY; ADSORPTION; | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2002-04-02 | — | — | US | claimed |
| US-20250059537-A1 | THERAPEUTIC OLIGONUCLEOTIDES HAVING AN INTER-NUCLEOSIDE AMIDE LINKAGE | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2025-02-20 | — | — | US | disclosed |
| EP-4448541-A1 | THERAPEUTIC OLIGONUCLEOTIDES HAVING AN INTER-NUCLEOSIDE AMIDE LINKAGE | Oxford University Innovation Limited (GB) | 2024-10-23 | — | — | EP | disclosed |
| WO-2023111597-A1 | THERAPEUTIC OLIGONUCLEOTIDES HAVING AN INTER-NUCLEOSIDE AMIDE LINKAGE | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2023-06-22 | — | — | WO | disclosed |
| WO-2022268932-A1 | SYSTEMS AND METHODS FOR SINGLE CELL ANALYSIS | THERMO FISHER SCIENTIFIC GENEART GMBH (DE) | 2022-12-29 | — | — | WO | disclosed |
| EP-3469009-B1 | SOLID SUPPORT | LIFE TECH AS (NO) | 2022-04-13 | — | — | EP | disclosed |
| US-11041068-B2 | Solid support | LIFE TECHNOLOGIES AS (NO) | 2021-06-22 | — | — | US | disclosed |
| US-20190264017-A1 | SOLID SUPPORT | LIFE TECHNOLOGIES AS (NO) | 2019-08-29 | — | — | US | disclosed |
| EP-3469009-A1 | SOLID SUPPORT | Life Technologies AS (NO) | 2019-04-17 | — | — | EP | disclosed |
| US-20180135099-A1 | NANOREPORTERS AND METHODS OF MANUFACTURING AND USE THEREOF | NANOSTRING TECHNOLOGIES, INC. | 2018-05-17 | — | — | US | disclosed |
| US-20020182602-A1 | Mobility-modified nucleobase polymers and methods of using same | APPLIED BIOSYSTEMS, INC. | 2002-12-05 | — | — | US | disclosed |
| WO-2002083954-A1 | MOBILITY-MODIFIED NUCLEOBASE POLYMERS AND METHODS OF USING SAME | APPLERA CORPORATION (US) | 2002-10-24 | — | — | WO | disclosed |
| WO-2002079516-A1 | NUCLEIC ACID ANALYSIS USING NON-TEMPLATED NUCLEOTIDE ADDITION | APPLERA CORPORATION (US) | 2002-10-10 | — | — | WO | disclosed |
| US-20020142342-A1 | Nucleic acid analysis using non-templated nucleotide addition | PE CORPORATION (NY) (US) | 2002-10-03 | — | — | US | disclosed |
| US-6365757-B1 | CULTURING TISSUES OF TAXUS WALLICHIANIA; ISOLATION BY PARTITIONING THE CULTURE PRODUCT RESIDUE, OBTAINED BY POLAR SOLVENT EXTRACTION; DESOLVENTIZING BETWEEN WATER AND CHLORINATED SOLVENTS; EVAPORATION; CHROMOTOGRAPHY; ADSORPTION; | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2002-04-02 | — | — | US | disclosed |
| WO-2002010182-A2 | METHODS FOR ISOLATING ONE STRAND OF A DOUBLE-STRANDED NUCLEIC ACID | APPLERA CORPORATION (US) | 2002-02-07 | — | — | WO | disclosed |
| EP-1148947-A1 | FIBRE ARRAY FOR CONTACTING CHEMICAL SPECIES AND METHODS FOR USING AND MAKING SAME | PE Corporation (NY) (US) | 2001-10-31 | — | — | EP | disclosed |
| WO-2000040334-A1 | FIBER ARRAY FOR CONTACTING CHEMICAL SPECIES AND METHODS FOR USING AND MAKING SAME | PE CORPORATION (NY) (US) | 2000-07-13 | — | — | WO | disclosed |
| WO-1999060170-A1 | LINEAR ARRAYS OF IMMOBILIZED COMPOUNDS AND METHODS OF USING SAME | HYSEQ, INC. (US) | 1999-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020182602-A1 | Mobility-modified nucleobase polymers and methods of using same | PCNA, PNKP, SAMHD1 | NUDT1 56/4885ADORA2A 1620/4885ADORA1 2191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.